ライフサイエンスコーパス: preventive

1 Development Center at the Agence de Medecine Preventive, a World Health Organization (WHO) Collaborat

2 hanical withdrawal threshold revealed a full preventive action against transient mechanical hypersens

3 Therefore, a joint preventive action plan needs to be developed for a bette

4 outcomes is important to implement specific preventive actions.

5 tially increasing trends of liver cancer for preventive actions.

6 We showed that ApN can act as a preventive agent and delay disease progression by reduci

7 action of DF as a therapeutic and potential preventive agent on the endothelial damage underlying di

8 Although the ideal preventive agent, an effective vaccine, is still some ti

9 hting the potential of vitamin D as a cancer-preventive agent.

10 monstrate a microneedle (MN)-based cutaneous preventive allergy treatment against ovalbumin (Ova)-ind

11 sion, better treatment during pregnancy, and preventive and clinical therapies for treatment of diabe

12 ards, Critical Control Points and associated preventive and corrective measures described.

13 s critical to designing diagnostic tools and preventive and corrective therapies.

14 origin, since veterinary drugs are used for preventive and curative purposes to treat animals.

15 lth system to design and implement effective preventive and intervention policies to reduce the burde

16 Preventive and intervention strategies aimed to reduce t

17 t in vivo miR-142-3p inhibition, either by a preventive and local treatment or by a therapeutic and s

18 for suspected neonatal infections to a basic preventive and promotive interventions package delivered

19 efforts should focus on identifying optimal preventive and screening measures for whole populations

20 hese discoveries will eventually lead to new preventive and therapeutic agents for obesity, this will

21 ems have the potential to revolutionize both preventive and therapeutic approaches for treating cardi

22 immune system will aid in the development of preventive and therapeutic approaches to combat this pai

23 n should be evaluated further as a potential preventive and therapeutic drug candidate for AD.

24 PT2385, a HIF-2alpha-specific inhibitor, had preventive and therapeutic effects on metabolic disorder

25 l as essential aspects to ultimately propose preventive and therapeutic measures.

26 Abs, in particular, have been tested in both preventive and therapeutic modalities.

27 ch interventions, may be potential and novel preventive and therapeutic options for patients with ADP

28 meliorated cardinal asthma manifestations in preventive and therapeutic protocols through generation

29 transfer of human act-A-iTr1 cells, both in preventive and therapeutic protocols, confers significan

30 Preventive and therapeutic research, surveillance, and q

31 ary to reveal the novel targets for regional preventive and therapeutic strategies development.

32 center stage for the development of improved preventive and therapeutic strategies for chronic progre

33 sal of CVD and aid in the development of new preventive and therapeutic strategies to limit the incre

34 forms the basis for designing cost-effective preventive and therapeutic strategies to slow the epidem

35 is critical for the development of improved preventive and therapeutic strategies.

36 might facilitate better immune control after preventive and therapeutic vaccination for HIV and for o

37 minate onchocerciasis are new tools, such as preventive and therapeutic vaccines.

38 Although preventive and treatment measures are well documented fo

39 delirium on long-term outcomes and possible preventive and treatment measures.

40 of NRG4 reduced chronic inflammation in both preventive and treatment studies, evidenced by lower mRN

41 iseases and also identifies novel windows of preventive and/or therapeutic interventions.

42 uncover methionine metabolism as a potential preventive and/or therapeutic target.

43 discovery will define potential diagnostic, preventive, and therapeutic opportunities for the corres

44 Combined analysis showed that preventive antifungal did not decrease mortality (risk r

45 ing pathophysiology in whom a therapeutic or preventive approach would be most useful.

46 Preventive approaches should take baseline cardiovascula

47 ed tumor growth being more noticeable in the preventive assay.

48 abinoids, to physical therapy strategies and preventive assistive devices.

49 me course, sun exposure, risk awareness, and preventive behavior.

50 respective fields of positive psychology and preventive cardiology.

51 exiting than those that remained in terms of preventive care (57.5% vs 60.4%; difference, 2.9% [95% C

52 men preferred that their PCPs handle general preventive care (79%) and comorbidity care (84%), but a

53 e-versus PCP-directed care-for their general preventive care (black odds ratio [OR], 2.01; 95% CI, 1.

54 a plan: 0.7-percentage point improvement in preventive care quality (95% CI, -4.9 to 6.3); 0.2-perce

55 Urban EDs serve patients with poor access to preventive care services who have a high prevalence of H

56 Law and strong, community-based primary and preventive care services, these values have resulted in

57 Children with early preventive care visits from dentists were more likely to

58 in the same county having higher quality for preventive care, 71.1% for chronic disease management, 6

59 ograms, screening for other cancers, general preventive care, and comorbidity management.

60 construct 3 composite indicators of quality (preventive care, chronic disease care management, and ma

61 provide critical knowledge for treatment and preventive care.

62 Repeated mass drug administration (MDA) with preventive chemotherapies is the mainstay of morbidity c

63 s than one-third of individuals who required preventive chemotherapies received treatment.

64 evise the global strategy and guidelines for preventive chemotherapy and complementary interventions

65 Both the preventive chemotherapy and hydrocele surgeries provided

66 o meet the 2020 target using the recommended preventive chemotherapy and morbidity management strateg

67 Snail control can complement preventive chemotherapy by reducing the risk of transmis

68 Unfortunately, despite the rise in preventive chemotherapy campaigns, just as many people s

69 n people in 88 countries have benefited from preventive chemotherapy in 2014.

70 the prevalence thresholds for cost-effective preventive chemotherapy of various strategies, and estim

71 l, administered at a single 40 mg/kg dose in preventive chemotherapy programs and 3 x 25 mg/kg for in

72 -year study of school-based and village-wide preventive chemotherapy strategies for Schistosoma manso

73 e cost-effectiveness and cost-benefit of the preventive chemotherapy that was provided under the GPEL

74 Our economic evaluation of preventive chemotherapy was based on previously publishe

75 ected cost-effectiveness and cost-benefit of preventive chemotherapy were very promising, and this wa

76 romises to strengthen early diagnosis, while preventive chemotherapy will reduce the risk of contacts

77 resolution and associated WHO guidelines on preventive chemotherapy.

78 ern wide-scale human treatment campaigns, or preventive chemotherapy.

79 onally, interest is growing in the design of preventive clinical trials in ARDS and to initiate early

80 physical activity, and nutrition, and three preventive consultations) plus omega 3 polyunsaturated f

81 Primary care provider-delivered preventive dental care did not significantly affect cari

82 with subsequent caries-related treatment and preventive dental care from PCPs.

83 To investigate the effectiveness of preventive dental care in reducing caries-related treatm

84 dental care, children with dentist-delivered preventive dental care more frequently had a subsequent

85 idence supporting the effectiveness of early preventive dental care or whether primary care providers

86 Children receiving preventive dental care prior to age 2 years from PCPs or

87 Dentist-delivered preventive dental care was associated with an increase i

88 Compared with matched children without early preventive dental care, children with dentist-delivered

89 le children, 25.8% (n = 3658) received early preventive dental care, of whom 44% were black, 37.6% we

90 e observed no evidence of a benefit of early preventive dental care, regardless of the provider.

91 necessary to elucidate any benefits of early preventive dental care.

92 d greater expenditures than children without preventive dental care.

93 r to age 2 years from PCPs or dentists vs no preventive dental care.

94 Despite advances in preventive, diagnostic, and therapeutic interventions, r

95 In 2 murine models we found a long-lasting preventive effect against experimental asthma features.

96 rhamnosus GG culture supernatant (LCS) has a preventive effect against gut-derived systemic neonatal

97 baseline depressive symptoms, PSE exerted a preventive effect among those with lower-level baseline

98 This preventive effect coincides with an extended preclinical

99 AIT is vast, the specific mechanisms for the preventive effect of primary sensitization or new sensit

100 e previously published in JEM a study on the preventive effect of tolerogenic vaccination with a stro

101 a published in our previous JEM paper on the preventive effect of tolerogenic vaccination with a stro

102 ven more, substantial evidence points to the preventive effect on the progression from rhinitis to as

103 nd 1.0 mg/cm(2) skin area) had a significant preventive effect on UVB-induced suppression of the CHS

104 e cohorts and provide estimates of potential preventive effect sizes in high-risk children.

105 However, this preventive effect was shown by only a few observational

106 The knowledge about lycopene's preventive effects in atherosclerosis, and other cardiov

107 In this study, we investigated the preventive effects of KJT on colon carcinogenesis using

108 The preventive effects were evaluated in human colonic carci

109 ocus frequent monitoring and more aggressive preventive efforts on high-risk patients.

110 of individuals who potentially benefit from preventive endografting is highly desirable.

111 ementation of an individualized provision of preventive focused interventions and improve outcomes of

112 However, the molecular basis of cancer preventive functions of zinc and its association with Or

113 tant implications for medical care delivery, preventive health practices, and resource allocation.

114 icipants infected in a randomized controlled preventive HIV-1 vaccine efficacy trial can help elucida

115 ts of sieve analyses performed on four major preventive HIV-1 vaccine efficacy trials: (i) the HIV Va

116 y exposed to tail mutilations in the form of preventive husbandry procedures (tail docking) or as a r

117 Preventive infusion of antibiotics in the mammary gland

118 0 IU/mL) warrants intensified diagnostic and preventive intervention because of the extremely high ri

119 is study was designed to determine whether a preventive intervention focused on enhancing supportive

120 that oxytocin administration is a promising preventive intervention for PTSD for individuals with hi

121 what modifiable factors can be targeted for preventive intervention.

122 d supplementation is a primary care-relevant preventive intervention.

123 but tools to identify high-risk patients and preventive interventions are missing.

124 There are currently few preventive interventions available for posttraumatic str

125 enomena to be included as targets in primary preventive interventions focusing on the child.

126 provide avenues for therapeutic and adjunct preventive interventions for both sporadic cancer as wel

127 Use of multifactorial preventive interventions for patients at high risk for d

128 e ICU, called UNDERPIN-ICU (nUrsiNg DEliRium Preventive INterventions in the ICU).

129 Preventive interventions post trauma are lacking.

130 of response to trauma, clinical evidence for preventive interventions remains sparse.

131 atives to identify those at risk and develop preventive interventions should be prioritized.

132 sion onset in infancy, it appears clear that preventive interventions should start early in pregnancy

133 e of vascular screening and consideration of preventive interventions to decrease vascular risk in al

134 nal mutations can help guide therapeutic and preventive interventions, but whether all of these inter

135 y and/or myopathy and the need for effective preventive interventions.

136 ths, respectively, providing clear focus for preventive interventions.

137 er's disease (AD) are a target for potential preventive interventions.

138 lity, and to identify those in most need for preventive interventions.

139 sease, providing an opportunity for targeted preventive interventions.

140 t satisfaction and increase effectiveness of preventive interventions.

141 icensure to fully evaluate the effect of RSV preventive interventions.

142 uicide attempts may be important targets for preventive interventions.

143 fied risk trajectory may be useful to target preventive interventions.

144 n of risk to have implications for targeting preventive interventions.

145 ing in asymptomatic individuals will lead to preventive lifestyle and medical interventions with pote

146 In the wet season, preventive malaria treatment was estimated to reduce the

147 nication package and provision of short-term preventive maternal and child health services and routin

148 the treatment of prebiotics could be a novel preventive measure against colorectal cancer (CRC) devel

149 ing the relevance of allergen avoidance as a preventive measure.

150 re of Japanese Governments has begun to take preventive measures against JC pollinosis and airborne p

151 e prevention of both diseases, several other preventive measures exist.

152 ass drug administration, bed nets, and other preventive measures has resulted in huge public health g

153 ials will allow us to routinely add targeted preventive measures in addition to human milk, such as p

154 st in decision-making about surveillance and preventive measures in EVD outbreaks.

155 us antimicrobial use, and the development of preventive measures including maternal vaccines are ongo

156 dentify aPL carriers at higher risk and take preventive measures on them.

157 Reductions in tobacco use, uptake of preventive measures, adoption of early detection methods

158 ore use of psychosocial assessment and other preventive measures, especially for young people and aga

159 Despite the above-mentioned preventive measures, it is also important to monitor hig

160 roaches for prostate cancer (PCa) lack early preventive measures, rapid diagnostic capabilities, risk

161 the first heatwave to maximize the impact of preventive measures.

162 of the risk factors and underlined possible preventive measures.

163 full effects and the corresponding need for preventive measures.

164 ents to decide on appropriate anti-infective preventive measures.

165 ld be no controversy about providing optimal preventive medication to these individuals.

166 ne per month, had failed at least 3 migraine preventive medications, and had significant right-to-lef

167 t contribution to human population research, preventive medicine, and public health is under substant

168 chemoprophylaxis, suggesting that additional preventive methods are needed.

169 erapeutic targets to lower amyloid-beta in a preventive mode, i.e., gamma- and beta-secretase; the ra

170 sia (BPD) in neonates, for which no specific preventive or therapeutic agent is available.

171 to develop safe and effective treatments, a preventive or therapeutic vaccine, and specific and sens

172 Ensuring adequate funding for dedicated, preventive paediatric care and taking action on a nation

173 The study has contributed to survey methods, preventive practice, nutrition science, and policy on he

174 Future UTI-preventive probiotic strains may benefit by retaining th

175 weight gain to inform the design of obesity-preventive programs in adolescents.

176 een conducted to assess the effectiveness of preventive psychological and/or educational intervention

177 inical trials assessing the effectiveness of preventive psychological and/or educational intervention

178 To evaluate the effectiveness of preventive psychological and/or educational intervention

179 d in identifying subjects in need of primary preventive regimens.

180 es in US stroke rates and offer insight into preventive risk-factor management strategies.

181 nc, an essential micronutrient, has a cancer preventive role.

182 Preventive salpingo-oophorectomy is currently the only m

183 amily communication, for improving uptake of preventive screening and surveillance in at-risk first-d

184 ecord (EHR) to include FBSE as a recommended preventive service for patients 35 years or older.

185 scientific evidence that the delivery of the preventive service leads to improvements in meaningful p

186 s and integrates the results of each to make preventive service recommendations.

187 Despite approximately equal access to preventive services and cancer care in this setting, we

188 rs at average risk for CRC who used Medicare preventive services and had no previous diagnostic or su

189 Strategies to improve access to preventive services are warranted.

190 ndations to primary care providers regarding preventive services for asymptomatic patients.

191 aps and research needs associated with these preventive services for these groups.

192 To compare the relative accuracy of US Preventive Services Task Force (USPSTF) and American Col

193 New recommendations from the US Preventive Services Task Force (USPSTF) emphasize therap

194 The US Preventive Services Task Force (USPSTF) makes recommenda

195 In July 2014, the U.S. Preventive Services Task Force (USPSTF) published a clin

196 ing decreased significantly following the US Preventive Services Task Force (USPSTF) recommendation a

197 To issue a new US Preventive Services Task Force (USPSTF) recommendation o

198 To update the 1996 US Preventive Services Task Force (USPSTF) recommendation o

199 To update the US Preventive Services Task Force (USPSTF) recommendation o

200 To update the 2010 US Preventive Services Task Force (USPSTF) recommendation o

201 To issue a new US Preventive Services Task Force (USPSTF) recommendation o

202 To issue a new US Preventive Services Task Force (USPSTF) recommendation o

203 To update the 2012 US Preventive Services Task Force (USPSTF) recommendation o

204 Objective: To update the 2008 US Preventive Services Task Force (USPSTF) recommendation o

205 To update the 2012 US Preventive Services Task Force (USPSTF) recommendation o

206 To update the 2011 US Preventive Services Task Force (USPSTF) recommendation o

207 To update the 2009 US Preventive Services Task Force (USPSTF) recommendation o

208 Preventive Services Task Force (USPSTF) summarizes the p

209 nation for gynecologic conditions for the US Preventive Services Task Force (USPSTF).

210 workshop was the recent reports from the US Preventive Services Task Force concluding that there was

211 Preventive Services Task Force endorsed aspirin for prim

212 venting neural tube defects to inform the US Preventive Services Task Force for an updated Recommenda

213 rompted an "I" rating from the United States Preventive Services Task Force for population-based skin

214 reastfeeding interventions to support the US Preventive Services Task Force in updating its 2008 reco

215 To update evidence for the US Preventive Services Task Force on the benefits and harms

216 videnced by the recent conclusions of the US Preventive Services Task Force on the need for further d

217 ta and assessed study quality using the U.S. Preventive Services Task Force quality rating criteria.

218 rs for Disease Control and Prevention and US Preventive Services Task Force recommend one-time hepati

219 treatment of blood cholesterol and 2016 U.S. Preventive Services Task Force recommendations for stati

220 n Heart Association guidelines and 2016 U.S. Preventive Services Task Force recommendations, respecti

221 More recently, the U.S. Preventive Services Task Force recommended "initiating l

222 Preventive Services Task Force recommended biennial mamm

223 s, and children 3 years and older for the US Preventive Services Task Force.

224 sia screening and risk assessment for the US Preventive Services Task Force.

225 racy, and treatment of OSA, to inform the US Preventive Services Task Force.

226 cardiovascular risk factors to inform the US Preventive Services Task Force.

227 en aged 6 months to 5 years to inform the US Preventive Services Task Force.

228 ncer in asymptomatic adults to inform the US Preventive Services Task Force.

229 in children and adolescents to inform the US Preventive Services Task Force.

230 ment with the chronic care model, and use of preventive services.

231 okinetic and pharmacodynamic considerations, preventive strategies (such as prophylaxis in MDR and XD

232 for the development of novel therapeutic and preventive strategies against E. faecalis and beyond.

233 and the implementation of early oral health preventive strategies are warranted to reduce the burden

234 fectiveness of currently available effective preventive strategies for contrast-induced acute kidney

235 The design of diagnostic and preventive strategies have been prevented by gaps in kno

236 hsTnI may have a role in personalizing preventive strategies in patients with diabetes mellitus

237 research is needed for better screening and preventive strategies to abrogate these toxic effects an

238 at may help develop novel therapeutic and/or preventive strategies to ameliorate pain in SCD.

239 sease (ASCVD) by implementing cardiovascular preventive strategies to manage the "ABCS" (aspirin ther

240 nicians to decide further biomarker testing, preventive strategies, and follow-up planning in patient

241 e for the development of future diagnostics, preventive strategies, and therapy for cardiovascular di

242 epresent attractive targets for antimalarial preventive strategies, yet the mechanisms of parasite en

243 ogenesis and may present a target for future preventive strategies.

244 portant for women and caregivers considering preventive strategies.

245 benefits and risks when combined with other preventive strategies.

246 mission models, which might influence future preventive strategies.

247 in unclear, which hinders the development of preventive strategies.

248 in low- and middle-income countries to guide preventive strategies.

249 Hydration alone was the least effective preventive strategy for CIAKI.

250 haps anticoagulation should be the preferred preventive strategy.

251 papillomas were treated by using a candidate preventive/therapeutic naked-DNA vaccine that expresses

252 monitoring response to treatments and novel preventive therapeutics need to be discovered, employed

253 cs will probably best serve as adjunctive or preventive therapies, which suggests that conventional a

254 ocedures and the safety and effectiveness of preventive therapies.

255 future cardiovascular events despite current preventive therapies.

256 The role of co-trimoxazole preventive therapy (CPT) in reducing leading causes of i

257 andates adequate attention to cardiovascular preventive therapy after diagnosis of breast cancer.

258 th Crotalus atrox venom (Cv-PC) as potential preventive therapy for reducing perioperative hemorrhage

259 P panel can refine risk in women who receive preventive therapy has not been directly assessed previo

260 ns for approaches to empirical treatment and preventive therapy in some regions of the world.

261 -reported symptoms on long-term adherence to preventive therapy in the United Kingdom sample of the I

262 urrent are promising candidates for an early preventive therapy in young phenotype-negative subjects

263 From the median time for preventive therapy initiation (50 days), fatal and nonfa

264 ial to benefit from more intensive secondary preventive therapy such as treatment with vorapaxar.

265 latent Mycobacterium tuberculosis infection (preventive therapy), shorten the time between disease on

266 Screening, preventive therapy, and surveillance for tuberculosis ar

267 ally despite the availability of life-saving preventive therapy, the implantable cardioverter defibri

268 men were attributing age-related symptoms to preventive therapy.

269 finding and increase uptake of tuberculosis preventive therapy.

270 evated risk of breast cancer and considering preventive therapy.

271 ients who are at risk of relapse in time for preventive therapy.

272 of intensified case finding and tuberculosis preventive therapy.

273 Intermittent preventive treatment (IPT) for malaria is used in infant

274 Intermittent preventive treatment (IPT) with sulphadoxine-pyrimethami

275 Fremanezumab as a preventive treatment for chronic migraine resulted in a

276 d peptide (CGRP), is being investigated as a preventive treatment for migraine.

277 In a recent trial of intermittent preventive treatment in pregnancy (IPTp) in Uganda, dihy

278 the continuing low coverage of intermittent preventive treatment of malaria in pregnancy (IPTp).

279 comes associated with CTE and for developing preventive treatment programs.

280 Preventive treatment that reduces CVD by even a small pe

281 ong pregnant women who received intermittent preventive treatment using sulfadoxine-pyrimethamine (IP

282 this study was to determine whether systemic preventive treatment with Aspirin-triggered RvD1 (AT-RvD

283 ascular Risk Using SIGN Guidelines to Assign Preventive Treatment]).

284 lying epileptogenesis and discover potential preventive treatments, the lack of PIE biomarkers hinder

285 The Multidomain Alzheimer Preventive Trial was a 3-year, multicentre, randomised,

286 aborations are needed for adequately powered preventive trials.

287 Our data show that preventive TSO treatment ameliorates colitis severity in

288 However, now there is effort to make a preventive vaccine against allergies.

289 usion, VGX-6150 appears safe and a promising preventive vaccine candidate for HCV infection.

290 route have been used as the primary mode of preventive vaccine delivery.

291 elopment, sexual transmission, and lack of a preventive vaccine have constituted a global health conc

292 enital viral infection, and development of a preventive vaccine is a high public health priority.

293 An effective preventive vaccine is highly sought after in order to st

294 A preventive vaccine would significantly impact the global

295 There are no antiviral drugs and no preventive vaccine.

296 response to accelerate the availability of a preventive vaccine.

297 disease and the mechanism by which candidate preventive vaccines potentially may confer protection pr

298 he expedited development and availability of preventive vaccines to protect against Zika virus diseas

299 ransfer of antibodies and the development of preventive vaccines, as well as immune-based therapeutic

300 Zika vaccines are the same as those of other preventive vaccines, unique considerations apply, in par